Evaluating Safety and Feasibility of Spinal Cord Decompression With or Without Nerve Graft Implantation After Acute Traumatic Spinal Cord Injury
Led by Francis Farhadi · Updated on 2025-12-10
10
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating treatments for acute traumatic spinal cord injury SCI, which often leads to paralysis, sensory changes, autonomic problems, and chronic pain. This pilot study aims to evaluate the safety, feasibility, and early effects of two surgical approaches dorsal myelotomy and expansive duraplasty DMED alone or combined with autologous nerve graft implantation ANGI. These techniques are studied to reduce secondary injury caused by pressure and tissue damage after SCI and to improve recovery outcomes.
The study randomly assigns ten participants to either receive DMED alone or DMED plus ANGI. Both groups undergo spinal cord decompression and stabilization through a posterior surgical approach within 48 hours of injury. The trial includes collecting excess sural nerve tissue for further analysis. Participants and outcome assessors are blinded to treatment allocation for unbiased results.
Participants will be monitored for 12 months, with repeated assessments including the Spinal Cord Independence Measure SCIM and the ASIA Impairment Scale AIS to evaluate functional recovery. Safety and feasibility of the procedures will be closely observed, along with neurocritical care standards and intraspinal pressure metrics. The data from this pilot will guide larger future studies to explore the effectiveness of these surgical interventions in acute SCI management.
CONDITIONS
Brief Title
Spinal Decompression Plus Nerve Graft Implantation Following TSCI
Research Team
F
Francis H Farhadi, MD, PhD
H
Harshit Arora, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Spinal Cord and Brain Injury Research Center (SCOBIRC)
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Decompression Plus Nerve Graft Implantation (DMED + ANGI)
Decompression With Stabilization (DMED)
What it is
Decompression and stabilization of the spinal cord by posterior approach, with additional implantation of autologous nerve tissue grafts.
Decompression and stabilization of the spinal cord using a posterior surgical approach.
Role in the trial
Investigational group receiving decompression, stabilization, and nerve graft implantation.
Serves as the active control group receiving the standard surgical decompression and stabilization.
Primary use
Investigates whether adding autologous nerve grafts to decompression and stabilization may improve recovery after acute spinal cord injury.
Urgent surgical intervention to decompress and stabilize the spinal cord soon after injury.
How it is given or performed
After decompression and stabilization, autologous nerve tissue is implanted during the same posterior surgical procedure.
Surgical decompression and stabilization are performed by posterior approach within 48 hours of injury.
Evidence status
Nerve graft implantation in this context is investigational. There are currently no published patient outcome results in humans, and evidence for efficacy or safety is not yet established.
Emergency decompression and stabilization are established procedures for acute non-penetrating spinal cord injury, but high-level evidence for the best timing and surgical approach continues to evolve.
Important limitations
The addition of nerve graft implantation is unproven in humans, and unknown risks, technical feasibility, and patient outcome effects are important uncertainties. Outcomes will depend on future study results.
While decompression and stabilization are standard in acute SCI, functional recovery is often limited, and the optimal strategy, timing, and long-term impact remain subjects of research.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 80Years
All Genders
Eligibility Criteria
You may qualify if you...
Age between 18 and 80 years
Written informed consent by patient or legal authorized representative
No other life-threatening injury
No evidence of sepsis
Acute cervical or thoracic spinal cord injury with ASIA Impairment Scale grade A or B on admission
Non-penetrating spinal cord injury at neurological level C2 to C8 or T1 to T12
Ability to undergo surgical intervention through a posterior approach within 48 hours of injury
You will not qualify if you...
Unconsciousness or mental impairment preventing neurological assessment within 48 hours
Acute spinal cord injury with ASIA Impairment Scale grade C, D, or E
Spinal cord decompression and stabilization safely performed through anterior-only approach
Current involvement in another non-observational spinal cord injury research or investigational drug use
Other illnesses, including mental disorders, that could affect medical or neurological evaluation
Inability to commit to follow-up schedule
Recent regular substance abuse that would interfere with participation
Any condition likely to cause death within 12 months
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surgery and Immediate Post-operative Care
Duration - Up to 48 hours after injury
Participants undergo spinal cord decompression with stabilization via a posterior approach, with or without implantation of autologous nerve grafts, as part of the surgical treatment.
1 surgical procedure and immediate hospital care
Post-operative Follow-up
Duration - Up to 12 months
Participants are monitored for recovery and outcomes following surgery, including assessments of neurological function and spinal cord independence.
Multiple follow-up visits over 12 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Evaluation of Blood Biomarkers to Classify Injury Severity and Predict Neurologic Recovery in Acute Traumatic Spinal Cord Injury Patients
Smart Home-Based Upper Limb Rehabilitation Using Robot and Task Training for Adults with Stroke and Spinal Cord Injuries
Using Abdominal Functional Electrical Stimulation to Improve Bowel Function in Adults with Spinal Cord Injury
Study of Activity-Based Therapy with Spinal Cord Stimulation to Improve Arm and Hand Function After Cervical Spinal Cord Injury
Effects of Spinal Cord Stimulation on Blood Pressure, Immune, and Cardiovascular Function in Adults with Spinal Cord Injury
One-Year Outpatient Rehabilitation Using the Atalante X Exoskeleton for Adults With Lower Limb Weakness or Deficiencies
Study of ARC-IM System Implant for Treating Blood Pressure Instability in Adults with Chronic Spinal Cord Injury
Using Artificial Intelligence with Radiomics and Genomics to Study Traumatic Cervical Spinal Cord Injury
Building a Comprehensive Spinal Cord Injury Data Platform for Research and Clinical Use
Study of a Robotic Exoskeleton for Upper Limb Rehabilitation in Adults with Spinal Cord Injuries
Evaluating Epidural Electrical Stimulation Combined with Automated Rehabilitation to Improve Motor, Bladder, and Sexual Functions in Adults with Incomplete Spinal Cord Injuries
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Design and protocol for the decompression-plus trial: a phase 1 clinical study of dorsal myelotomy and expansive duroplasty with or without autologous nerve grafting in acute traumatic spinal cord injury.
Zahraa Al-Sharshahi, Jared T Wilcox, Hassan Darabi...